Butylamine Details
: IUPAC Name
:Chemical Class
:CAS Registry Number
109-73-9
:Description
:Fragrance Type
Ammoniacal aroma??
Physical and Chemical properties
| PUBCHEM ID | 8007 |
| Molecular Weight (mg/mol) | 73.139 |
| Molecular Formula | C4H11N |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 2 |
| IUPAC Name | |
| Canonical SMILES | CCCCN |
| PUBCHEM IUPAC INCHIKEY | HQABUPZFAYXKJW-UHFFFAOYSA-N |
| Solubility Level | 4 |
| Vapour Pressure | -7.141 |
Absorption and Metabolism information
| XLOGP3 AA | NA |
| CACTVS TPSA | 37.29 |
| BBB Level | 2 |
| Absorption Level | 0 |
| EXT PPB#Prediction | 0 |
| AlogP98 | 0.681 |
| EXT CYP2D6#Prediction | 0 |
Toxicological Information
| Mouse Female FDA | Non-Carcinogen |
| Mouse Male FDA | Multi-Carcinogen |
| Rat Female FDA | Single-Carcinogen |
| Rat Male FDA | Non-Carcinogen |
| Ames Prediction | Non-Mutagen |
| Developmental / Reproductive Toxicity | Toxic |
| Rat Oral LD50 | 0.345315 |
| Ocular Irritancy | Severe |
| Hepatotoxic#Prediction | 0 |
| Effected Human Genes | NA |
Ecological Information
| Aerobic Biodegradability Prediction | Degradable |
Hazard(s) Identification
| Physical hazards | not classified |
| Health hazards | Mild |
| Environmental hazards | not classified |
Compound Biological Activity
| Serial No. | Cas No | Gene Symbol | Organism | Interaction | Interaction Actions | PubMed Id |
|---|---|---|---|---|---|---|
| 1 | 109-73-9 | INS | Mus musculus | [1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased abundance of n-butylamine analog | affects^cotreatment|increases^abundance | 26820058 |
| 2 | 109-73-9 | INS | Mus musculus | [1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased abundance of n-butylamine analog | affects^cotreatment|increases^abundance | 26820058 |
| 3 | 109-73-9 | INS | Mus musculus | [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased abundance of n-butylamine analog | affects^cotreatment|increases^abundance | 26820058 |
| 4 | 109-73-9 | INS | Mus musculus | [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased abundance of n-butylamine analog | affects^cotreatment|increases^abundance | 26820058 |
| Serial No. | Activity Name | Details | References (PubMed) | Other details EPA (U.S) | Clinical Trials (U.S. NIH) |
|---|---|---|---|---|---|
| 1 | 109-73-9 | Butylamine |
Compound Image
2D Structure
Download Sdf File Download PDB File Download MOL File
View Similar Structures (External DB)